Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.0029.03%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.49M | 4.35M | 5.14M | 6.07M | 7.32M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 57.10K | 42.00K | 26.90K | 63.20K | 75.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.55M | 4.39M | 5.16M | 6.13M | 7.40M |
|
|
|||||
| Total Current Assets | 3.55M | 4.39M | 5.16M | 6.13M | 7.40M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.55M | 4.39M | 5.16M | 6.13M | 7.40M |
|
|
|||||
| Total Accounts Payable | 97.30K | 133.30K | 83.90K | 421.10K | 970.00K |
| Total Accrued Expenses | 216.50K | 190.60K | 142.50K | 512.00K | 260.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.53M | 2.30M | 2.07M | 1.83M | 1.72M |
| Total Other Current Liabilities | 2.53M | 2.30M | 2.07M | 1.83M | 1.72M |
| Total Current Liabilities | 2.84M | 2.62M | 2.29M | 2.77M | 2.95M |
|
|
|||||
| Total Current Liabilities | 2.84M | 2.62M | 2.29M | 2.77M | 2.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.84M | 2.62M | 2.29M | 2.77M | 2.95M |
|
|
|||||
| Common Stock & APIC | 113.94M | 114.05M | 114.17M | 114.33M | 114.48M |
| Retained Earnings | -113.24M | -112.28M | -111.29M | -110.96M | -110.04M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 700.90K | 1.77M | 2.87M | 3.37M | 4.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 700.90K | 1.77M | 2.87M | 3.37M | 4.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 700.90K | 1.77M | 2.87M | 3.37M | 4.45M |
|
|
|||||